Introduction from the chair
It gives me great pleasure to introduce the Human Tissue Authority’s updated strategy for 2019-22 in my capacity as the Interim Chair of the Authority. Our 2019 – 22 strategy builds on the comprehensive evaluation we conducted before developing our last 3-year strategy, and continues to focus on the three key areas of sustainability, resilience, and agility. Major themes for the next three years will continue to be a renewed focus on our people, our technology, how we collect and use information, and managing our finances.
You will see in this document that what we do, and how we do it, have not been subject to a fundamental change, and that our guiding principles, values, and key activities remain the same.
We will continue to license and inspect establishments, in order to monitor compliance with legislation and best practice and take action where it is required.
We will continue to provide advice and guidance to the public and professionals with an interest in the areas we work in, and involve them in our work where appropriate.
We will continue to work closely with our key partners across the system in order to ensure a consistent and joined up approach nationally.
And, we will continue to ensure that we maintain public confidence in the systems we regulate, through an open and transparent approach to reporting and acting in an effective manner on any serious failures uncovered or concerns held.
Behind this activity, we will continue with our programme of work that is examining how we can most effectively deliver our services for the next three years, and into the future. This work will address, amongst other things, how we can better ensure that: we use our intelligence and knowledge of risk to support our inspection programme and inform our proportionate regulatory approach; we engage with and involve the public and professionals through as wide variety of channels as possible; and seek out new and useful ways to build and strengthen relationships with others. A key theme in this work will be identifying how we can work smarter, making best use of the resources available to us, streamlining our processes and ensuring that we do not undertake any activity that does not support the delivery of our goals.
We anticipate that the next few years will be a challenging period, but with this challenge will come a number of opportunities, opportunities that we intend to grasp.
I do hope that you find this strategy a useful and interesting read, and I look forward to continuing to work with you on ensuring the highest standards for UK establishments that use human bodies, body parts, organs, and tissue in their work.